Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility.

Sud A, Thomsen H, Law PJ, Försti A, Filho MIDS, Holroyd A, Broderick P, Orlando G, Lenive O, Wright L, Cooke R, Easton D, Pharoah P, Dunning A, Peto J, Canzian F, Eeles R, Kote-Jarai Z, Muir K, Pashayan N; PRACTICAL consortium, Hoffmann P, Nöthen MM, Jöckel KH, Strandmann EPV, Lightfoot T, Kane E, Roman E, Lake A, Montgomery D, Jarrett RF, Swerdlow AJ, Engert A, Orr N, Hemminki K, Houlston RS.

Nat Commun. 2017 Dec 1;8(1):1892. doi: 10.1038/s41467-017-00320-1.

2.

Inherited Chromosomally Integrated Human Herpesvirus 6 Genomes Are Ancient, Intact, and Potentially Able To Reactivate from Telomeres.

Zhang E, Bell AJ, Wilkie GS, Suárez NM, Batini C, Veal CD, Armendáriz-Castillo I, Neumann R, Cotton VE, Huang Y, Porteous DJ, Jarrett RF, Davison AJ, Royle NJ.

J Virol. 2017 Oct 27;91(22). pii: e01137-17. doi: 10.1128/JVI.01137-17. Print 2017 Nov 15.

3.

Optimisation and validation of a PCR for antigen receptor rearrangement (PARR) assay to detect clonality in canine lymphoid malignancies.

Waugh EM, Gallagher A, Haining H, Johnston PEJ, Marchesi F, Jarrett RF, Morris JS.

Vet Immunol Immunopathol. 2016 Dec;182:115-124. doi: 10.1016/j.vetimm.2016.10.008. Epub 2016 Oct 19.

4.

A susceptibility locus for classical Hodgkin lymphoma at 8q24 near MYC/PVT1 predicts patient outcome in two independent cohorts.

Ghesquières H, Larrabee BR, Casasnovas O, Maurer MJ, McKay JD, Ansell SM, Montgomery D, Asmann YW, Farrell K, Verney A, Slager SL, Allmer C, Perrot A, Delarue R, Habermann TM, Dupuis J, Link BK, Canioni D, Dogan A, Cozen W, Jarrett RF, Cerhan JR, Salles G.

Br J Haematol. 2018 Jan;180(2):286-290. doi: 10.1111/bjh.14306. Epub 2016 Sep 9. No abstract available.

PMID:
27716907
5.

HHV-8-unrelated primary effusion-like lymphoma associated with clonal loss of inherited chromosomally-integrated human herpesvirus-6A from the telomere of chromosome 19q.

Zhang E, Cotton VE, Hidalgo-Bravo A, Huang Y, Bell AJ, Jarrett RF, Wilkie GS, Davison AJ, Nacheva EP, Siebert R, Majid A, Kelpanides I, Jayne S, Dyer MJ, Royle NJ.

Sci Rep. 2016 Mar 7;6:22730. doi: 10.1038/srep22730.

6.

A Novel Risk Locus at 6p21.3 for Epstein-Barr Virus-Positive Hodgkin Lymphoma.

Delahaye-Sourdeix M, Urayama KY, Gaborieau V, Veenstra R, Foll M, Chabrier A, Benavente Y, Nieters A, Becker N, Foretova L, Maynadié M, Staines A, Smedby KE, Glimelius I, Lightfoot T, Cocco P, Galan P, Vatten LJ, Duell EJ, Kiemeney L, Roman E, de Sanjosé S, Lathrop M, Melbye M, Brennan P, Diepstra A, van den Berg A, Hjalgrim H, Jarrett RF, McKay JD.

Cancer Epidemiol Biomarkers Prev. 2015 Dec;24(12):1838-43. doi: 10.1158/1055-9965.EPI-15-0534. Epub 2015 Sep 24.

7.

Human leukocyte antigens and genetic susceptibility to lymphoma.

McAulay KA, Jarrett RF.

Tissue Antigens. 2015 Aug;86(2):98-113. doi: 10.1111/tan.12604. Review.

PMID:
26189878
8.

Gammaherpesviruses and canine lymphoma: no evidence for direct involvement in commonly occurring lymphomas.

Waugh EM, Gallagher A, McAulay KA, Henriques J, Alves M, Bell AJ, Morris JS, Jarrett RF.

J Gen Virol. 2015 Jul;96(Pt 7):1863-72. doi: 10.1099/vir.0.000106. Epub 2015 Feb 26.

9.

Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis.

Johnson PC, McAulay KA, Montgomery D, Lake A, Shield L, Gallagher A, Little AM, Shah A, Marsh SG, Taylor GM, Jarrett RF.

Int J Cancer. 2015 Sep 1;137(5):1066-75. doi: 10.1002/ijc.29467. Epub 2015 Feb 20.

10.

Germ-line transmitted, chromosomally integrated HHV-6 and classical Hodgkin lymphoma.

Bell AJ, Gallagher A, Mottram T, Lake A, Kane EV, Lightfoot T, Roman E, Jarrett RF.

PLoS One. 2014 Nov 10;9(11):e112642. doi: 10.1371/journal.pone.0112642. eCollection 2014.

11.

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.

Cozen W, Timofeeva MN, Li D, Diepstra A, Hazelett D, Delahaye-Sourdeix M, Edlund CK, Franke L, Rostgaard K, Van Den Berg DJ, Cortessis VK, Smedby KE, Glaser SL, Westra HJ, Robison LL, Mack TM, Ghesquieres H, Hwang AE, Nieters A, de Sanjose S, Lightfoot T, Becker N, Maynadie M, Foretova L, Roman E, Benavente Y, Rand KA, Nathwani BN, Glimelius B, Staines A, Boffetta P, Link BK, Kiemeney L, Ansell SM, Bhatia S, Strong LC, Galan P, Vatten L, Habermann TM, Duell EJ, Lake A, Veenstra RN, Visser L, Liu Y, Urayama KY, Montgomery D, Gaborieau V, Weiss LM, Byrnes G, Lathrop M, Cocco P, Best T, Skol AD, Adami HO, Melbye M, Cerhan JR, Gallagher A, Taylor GM, Slager SL, Brennan P, Coetzee GA, Conti DV, Onel K, Jarrett RF, Hjalgrim H, van den Berg A, McKay JD.

Nat Commun. 2014 Jun 12;5:3856. doi: 10.1038/ncomms4856.

12.

Variation at 3p24.1 and 6q23.3 influences the risk of Hodgkin's lymphoma.

Frampton M, da Silva Filho MI, Broderick P, Thomsen H, Försti A, Vijayakrishnan J, Cooke R, Enciso-Mora V, Hoffmann P, Nöthen MM, Lloyd A, Holroyd A, Eisele L, Jöckel KH, Ponader S, von Strandmann EP, Lightfoot T, Roman E, Lake A, Montgomery D, Jarrett RF, Swerdlow AJ, Engert A, Hemminki K, Houlston RS.

Nat Commun. 2013;4:2549. doi: 10.1038/ncomms3549.

13.

Molecular methods of virus detection in lymphoma.

Jarrett RF, Gallagher A, Gatherer D.

Methods Mol Biol. 2013;971:277-93. doi: 10.1007/978-1-62703-269-8_16.

PMID:
23296970
14.

Human tissues contain CD141hi cross-presenting dendritic cells with functional homology to mouse CD103+ nonlymphoid dendritic cells.

Haniffa M, Shin A, Bigley V, McGovern N, Teo P, See P, Wasan PS, Wang XN, Malinarich F, Malleret B, Larbi A, Tan P, Zhao H, Poidinger M, Pagan S, Cookson S, Dickinson R, Dimmick I, Jarrett RF, Renia L, Tam J, Song C, Connolly J, Chan JK, Gehring A, Bertoletti A, Collin M, Ginhoux F.

Immunity. 2012 Jul 27;37(1):60-73. doi: 10.1016/j.immuni.2012.04.012. Epub 2012 Jul 12.

15.

Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.

Urayama KY, Jarrett RF, Hjalgrim H, Diepstra A, Kamatani Y, Chabrier A, Gaborieau V, Boland A, Nieters A, Becker N, Foretova L, Benavente Y, Maynadié M, Staines A, Shield L, Lake A, Montgomery D, Taylor M, Smedby KE, Amini RM, Adami HO, Glimelius B, Feenstra B, Nolte IM, Visser L, van Imhoff GW, Lightfoot T, Cocco P, Kiemeney L, Vermeulen SH, Holcatova I, Vatten L, Macfarlane GJ, Thomson P, Conway DI, Benhamou S, Agudo A, Healy CM, Overvad K, Tjønneland A, Melin B, Canzian F, Khaw KT, Travis RC, Peeters PH, González CA, Quirós JR, Sánchez MJ, Huerta JM, Ardanaz E, Dorronsoro M, Clavel-Chapelon F, Bueno-de-Mesquita HB, Riboli E, Roman E, Boffetta P, de Sanjosé S, Zelenika D, Melbye M, van den Berg A, Lathrop M, Brennan P, McKay JD.

J Natl Cancer Inst. 2012 Feb 8;104(3):240-53. doi: 10.1093/jnci/djr516. Epub 2012 Jan 27.

16.

The retrovirus XMRV is not directly involved in the pathogenesis of common types of lymphoid malignancy.

Waugh EM, Jarrett RF, Shield L, Montgomery D, Dean RT, Mitchell A, Greaves MF, Gallagher A.

Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2232-6. doi: 10.1158/1055-9965.EPI-11-0561. Epub 2011 Aug 22.

17.

The molecular pathogenesis of Hodgkin lymphoma.

Farrell K, Jarrett RF.

Histopathology. 2011 Jan;58(1):15-25. doi: 10.1111/j.1365-2559.2010.03705.x. Review.

PMID:
21261680
18.

A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3).

Enciso-Mora V, Broderick P, Ma Y, Jarrett RF, Hjalgrim H, Hemminki K, van den Berg A, Olver B, Lloyd A, Dobbins SE, Lightfoot T, van Leeuwen FE, Försti A, Diepstra A, Broeks A, Vijayakrishnan J, Shield L, Lake A, Montgomery D, Roman E, Engert A, von Strandmann EP, Reiners KS, Nolte IM, Smedby KE, Adami HO, Russell NS, Glimelius B, Hamilton-Dutoit S, de Bruin M, Ryder LP, Molin D, Sorensen KM, Chang ET, Taylor M, Cooke R, Hofstra R, Westers H, van Wezel T, van Eijk R, Ashworth A, Rostgaard K, Melbye M, Swerdlow AJ, Houlston RS.

Nat Genet. 2010 Dec;42(12):1126-1130. doi: 10.1038/ng.696. Epub 2010 Oct 31.

19.

Mannose-binding lectin genotypes and susceptibility to epstein-barr virus infection in infancy.

Friborg JT, Jarrett RF, Koch A, Garred P, Freeland JM, Andersen A, Melbye M.

Clin Vaccine Immunol. 2010 Sep;17(9):1484-7. doi: 10.1128/CVI.00527-09. Epub 2010 Jul 7.

20.

SLC6A4 expression and anti-proliferative responses to serotonin transporter ligands chlomipramine and fluoxetine in primary B-cell malignancies.

Chamba A, Holder MJ, Jarrett RF, Shield L, Toellner KM, Drayson MT, Barnes NM, Gordon J.

Leuk Res. 2010 Aug;34(8):1103-6. doi: 10.1016/j.leukres.2010.03.007. Epub 2010 Apr 2.

PMID:
20363025
21.

HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma.

Hjalgrim H, Rostgaard K, Johnson PC, Lake A, Shield L, Little AM, Ekstrom-Smedby K, Adami HO, Glimelius B, Hamilton-Dutoit S, Kane E, Taylor GM, McConnachie A, Ryder LP, Sundstrom C, Andersen PS, Chang ET, Alexander FE, Melbye M, Jarrett RF.

Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6400-5. doi: 10.1073/pnas.0915054107. Epub 2010 Mar 22.

22.

Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases.

Lake A, Shield LA, Cordano P, Chui DT, Osborne J, Crae S, Wilson KS, Tosi S, Knight SJ, Gesk S, Siebert R, Hay RT, Jarrett RF.

Int J Cancer. 2009 Sep 15;125(6):1334-42. doi: 10.1002/ijc.24502.

23.

Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22.

Niens M, Visser L, Nolte IM, van der Steege G, Diepstra A, Cordano P, Jarrett RF, Te Meerman GJ, Poppema S, van den Berg A.

Br J Haematol. 2008 Mar;140(5):527-36. doi: 10.1111/j.1365-2141.2007.06964.x.

PMID:
18275430
24.

Epstein-Barr virus immune response in high-risk nasopharyngeal carcinoma families in Greenland.

Friborg J, Jarrett RF, Liu MY, Falk KI, Koch A, Olsen OR, Duncan P, Wohlfarht J, Chen JY, Melbye M.

J Med Virol. 2007 Dec;79(12):1877-81.

PMID:
17935169
25.

HLA class I polymorphisms are associated with development of infectious mononucleosis upon primary EBV infection.

McAulay KA, Higgins CD, Macsween KF, Lake A, Jarrett RF, Robertson FL, Williams H, Crawford DH.

J Clin Invest. 2007 Oct;117(10):3042-8.

26.

HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma.

Niens M, Jarrett RF, Hepkema B, Nolte IM, Diepstra A, Platteel M, Kouprie N, Delury CP, Gallagher A, Visser L, Poppema S, te Meerman GJ, van den Berg A.

Blood. 2007 Nov 1;110(9):3310-5. Epub 2007 Jul 13.

27.

Measles virus and classical Hodgkin lymphoma: no evidence for a direct association.

Wilson KS, Freeland JM, Gallagher A, Cosby SL, Earle JA, Alexander FE, Taylor GM, Jarrett RF.

Int J Cancer. 2007 Jul 15;121(2):442-7.

28.

The human leukocyte antigen class I region is associated with EBV-positive Hodgkin's lymphoma: HLA-A and HLA complex group 9 are putative candidate genes.

Niens M, van den Berg A, Diepstra A, Nolte IM, van der Steege G, Gallagher A, Taylor GM, Jarrett RF, Poppema S, te Meerman GJ.

Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2280-4.

29.

Viruses and Hodgkin lymphoma: no evidence of polyomavirus genomes in tumor biopsies.

Wilson KS, Gallagher A, Freeland JM, Shield LA, Jarrett RF.

Leuk Lymphoma. 2006 Jul;47(7):1315-21.

PMID:
16923562
30.

Molecular methods for virus discovery.

Jarrett RF, Johnson D, Wilson KS, Gallagher A.

Dev Biol (Basel). 2006;123:77-88; discussion 119-32.

PMID:
16566437
31.

The putative role of transforming viruses in childhood acute lymphoblastic leukemia.

MacKenzie J, Greaves MF, Eden TO, Clayton RA, Perry J, Wilson KS, Jarrett RF.

Haematologica. 2006 Feb;91(2):240-3.

32.

Viruses and lymphoma/leukaemia.

Jarrett RF.

J Pathol. 2006 Jan;208(2):176-86. Review.

PMID:
16362996
33.

Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study.

Jarrett RF, Stark GL, White J, Angus B, Alexander FE, Krajewski AS, Freeland J, Taylor GM, Taylor PR; Scotland and Newcastle Epidemiology of Hodgkin Disease Study Group.

Blood. 2005 Oct 1;106(7):2444-51. Epub 2005 Jun 7.

34.

Phenotype and frequency of Epstein-Barr virus-infected cells in pretreatment blood samples from patients with Hodgkin lymphoma.

Khan G, Lake A, Shield L, Freeland J, Andrew L, Alexander FE, Jackson R, Taylor PR, McCruden EA, Jarrett RF.

Br J Haematol. 2005 May;129(4):511-9.

PMID:
15877733
35.

Germline mutations and polymorphisms in the NFKBIA gene in Hodgkin lymphoma.

Osborne J, Lake A, Alexander FE, Taylor GM, Jarrett RF.

Int J Cancer. 2005 Sep 10;116(4):646-51.

36.

Effect of IL-6 promoter polymorphism on incidence and outcome in Hodgkin's lymphoma.

Cordano P, Lake A, Shield L, Taylor GM, Alexander FE, Taylor PR, White J, Jarrett RF.

Br J Haematol. 2005 Feb;128(4):493-5.

PMID:
15686457
38.

Interdigitating dendritic cell sarcoma of salivary gland associated lymphoid tissue not associated with HHV-8 or EBV infection.

Barwell N, Howatson R, Jackson R, Johnson A, Jarrett RF, Cook G.

J Clin Pathol. 2004 Jan;57(1):87-9.

39.

The Scotland and Newcastle epidemiological study of Hodgkin's disease: impact of histopathological review and EBV status on incidence estimates.

Jarrett RF, Krajewski AS, Angus B, Freeland J, Taylor PR, Taylor GM, Alexander FE.

J Clin Pathol. 2003 Nov;56(11):811-6. Erratum in: J Clin Pathol. 2004 Jan;57(1):112.

40.

An epidemiologic study of index and family infectious mononucleosis and adult Hodgkin's disease (HD): evidence for a specific association with EBV+ve HD in young adults.

Alexander FE, Lawrence DJ, Freeland J, Krajewski AS, Angus B, Taylor GM, Jarrett RF.

Int J Cancer. 2003 Nov 1;107(2):298-302.

41.

Classical Hodgkin lymphoma is associated with frequent gains of 17q.

Chui DT, Hammond D, Baird M, Shield L, Jackson R, Jarrett RF.

Genes Chromosomes Cancer. 2003 Oct;38(2):126-36.

PMID:
12939740
42.

Association between simian virus 40 DNA and lymphoma in the United kingdom.

MacKenzie J, Wilson KS, Perry J, Gallagher A, Jarrett RF.

J Natl Cancer Inst. 2003 Jul 2;95(13):1001-3.

PMID:
12837836
43.

Hodgkin lymphoma and Epstein-Barr virus (EBV): no evidence to support hit-and-run mechanism in cases classified as non-EBV-associated.

Gallagher A, Perry J, Freeland J, Alexander FE, Carman WF, Shield L, Cartwright R, Jarrett RF.

Int J Cancer. 2003 May 1;104(5):624-30.

44.

Viruses and Hodgkin disease: no evidence of novel herpesviruses in non-EBV-associated lesions.

Gallagher A, Perry J, Shield L, Freeland J, MacKenzie J, Jarrett RF.

Int J Cancer. 2002 Sep 20;101(3):259-64.

45.

Viruses and Hodgkin's lymphoma.

Jarrett RF.

Ann Oncol. 2002;13 Suppl 1:23-9. Review.

PMID:
12078898
46.

Primary T cell lymphoma of salivary gland: a report of a case and review of the literature.

Hew WS, Carey FA, Kernohan NM, Heppleston AD, Jackson R, Jarrett RF.

J Clin Pathol. 2002 Jan;55(1):61-3. Review.

47.

Posttransplant lymphoproliferative disorder associated with primate gamma-herpesvirus in cynomolgus monkeys used in pig-to-primate renal xenotransplantation and primate renal allotransplantation.

McInnes EF, Jarrett RF, Langford G, Atkinson C, Horsley J, Goddard MJ, Cozzi E, Schuurman HJ.

Transplantation. 2002 Jan 15;73(1):44-52.

PMID:
11792976
48.
49.

Epstein-Barr Virus and HLA-DPB1-*0301 in young adult Hodgkin's disease: evidence for inherited susceptibility to Epstein-Barr Virus in cases that are EBV(+ve).

Alexander FE, Jarrett RF, Cartwright RA, Armstrong AA, Gokhale DA, Kane E, Gray D, Lawrence DJ, Taylor GM.

Cancer Epidemiol Biomarkers Prev. 2001 Jun;10(6):705-9.

50.

Screening for herpesvirus genomes in common acute lymphoblastic leukemia.

MacKenzie J, Gallagher A, Clayton RA, Perry J, Eden OB, Ford AM, Greaves MF, Jarrett RF.

Leukemia. 2001 Mar;15(3):415-21.

PMID:
11237065

Supplemental Content

Loading ...
Support Center